Background: The clustering of sleep alterations, cardiometabolic risk, and depressive symptoms suggests a convergence in their pathophysiology. We quantify the role of depressive symptoms in mediating the association between empirically derived sleep indices and body mass index (BMI).
Methods: Data were derived from 8,844 adult participants of the 2005 to 2008 US National Health and Nutrition Examination Survey.
Background: The relationship between obesity and depression is complex. This study assessed the impact of body mass index (BMI) on the link between BMI, inflammation, oxidative stress, sleep quality and self-reported depressive symptoms.
Methods: We used data from the U.
Objective: The 2013 Diabetes Canada guidelines launched targeted dissemination tools and a simple assessment for vascular protection. We aimed to ) examine changes associated with the launch of the 2013 guidelines and additional dissemination efforts in the rates of vascular protective medications prescribed in primary care for older patients with diabetes and ) examine differences in the rates of prescriptions of vascular protective medications by patient and provider characteristics.
Research Design And Methods: The study population included patients (≥40 years of age) from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) with type 2 diabetes and at least one clinic visit from April 2010 to December 2015.
Objectives: This research examines the feasibility of using electronic medical records within the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) for obesity surveillance in Canada by assessing obesity trends over time and comparing BMI distribution estimates from CPCSSN to those obtained from nationally representative surveys.
Methods: Data from 2003-2012 on patients 18 years and older (n = 216,075) were extracted from the CPCSSN database. Patient information included demographics (age and sex) and anthropometric measures (height, weight, body mass index (BMI), waist circumference, and waist-to-hip ratio).